Laid off from Sanofi.

Since 2021, several of Sanofi's American layoffs have come after it bought a biotech company and, within a few years, decided to close that company's labs or offices. Blueprint Medicines in Cambridge is the latest. Earlier cuts included sales representatives and Chattanooga jobs bound for New Jersey.

What we know about Sanofi severance and layoffs

  • 229 Blueprint Medicines jobs on Sanofi's August 2026 notice to Massachusetts
  • 1,700 US jobs Sanofi-Aventis said in October 2010 it was cutting, mostly sales
  • 689 Bridgewater jobs on a 2004 Sanofi-Aventis filing, Sanofi's largest in our tracker
  • 100 jobs on Sanofi's April 2024 California closing notice, tied to divesting Amunix
  • 180 jobs on Sanofi US's 2018 Tennessee notice, 160 from the Chattanooga office

The most recent Sanofi layoff we've found

Sanofi was laying off 229 former Blueprint Medicines employees in Cambridge, according to pharmaphorum's report in August 2026, and Sanofi tied the decisions to integrating the company after buying it in July 2025.

What Sanofi layoffs have meant for employees

Blueprint staff who stayed were reporting to Sanofi's East Cambridge office, according to pharmaphorum's report, and Sanofi employed nearly 4,200 people in Massachusetts in 2025, the Boston Globe reported, citing the Boston Business Journal. Sanofi also said many Blueprint employees were joining it and that it would keep supporting those affected through the transition. If that support includes outplacement or job-search help, starting it while you're still employed gives it more time to work.

Four of the five American cuts on record since 2021 were at companies Sanofi had bought. The fifth reshaped its own vaccine sales unit, BioSpace reported, and the same report tied the Amunix job cuts to Sanofi's decision to sell that business. At Kadmon and at Blueprint, Sanofi called the decisions part of integration, according to a 2022 BioSpace report and pharmaphorum. For people who came in with those companies, the deal started a clock. Principia, bought in 2020, had its labs shut the next year, according to BioSpace's 2021 report and the 2022 one, and the Amunix jobs were set to go about two and a half years after Sanofi bought that company. Kadmon's site exit was decided six months after that purchase closed, and the Blueprint notice came just over a year after that deal. If the Kadmon or Blueprint closing ended your job and an interviewer asks why, you can give Sanofi's explanation, that it was integrating a company it had bought, and there's more in how to explain a layoff.

In 2018, 2022 and 2024, Sanofi invited people its cuts affected to apply for other Sanofi jobs, and in 2018 the roles on offer to Chattanooga's consumer health staff were in Bridgewater, New Jersey. That move took marketing, sales, research and support jobs, while Sanofi said it would keep its Chattanooga manufacturing and 650 jobs there, the Times Free Press reported. If Sanofi offers you a role in another state, you could add up the cost of the move and of housing there.

Sanofi's sales force has taken cuts more than once, and where Sanofi gave a reason, it pointed to its products' markets. The 2010 cut followed sales-force reductions that June and the November before, the Associated Press reported, and that cut alone was about 13 percent of the 13,000 people Sanofi then employed in the United States, a count that took in research, manufacturing, the Sanofi Pasteur vaccines business and the consumer products subsidiary Chattem. AP also noted a research site downsized in Great Valley, Pennsylvania, and a Kansas City manufacturing plant Sanofi was closing in phases through 2012, with about 300 jobs going there. In 2024 a spokesperson put the vaccine sales overhaul down to an evolving U.S. vaccines market.

If you work in what was Sanofi's consumer health business, control of it changed hands in 2025. On April 30 that year Sanofi sold a 50.0% controlling stake in the business, Opella, to CD&R and kept 48.2%, calling itself a pure-play biopharma afterward, according to Sanofi's release, and our WARN tracker leaves Opella and Chattem filings out of Sanofi's count. The 2018 Chattanooga cut was Sanofi's own, made while it still ran that business.

Kadmon's 2022 New York exit predates our tracker's New York records, which begin in 2026, so no filing for it can appear. If your Sanofi job was in Massachusetts, California or New Jersey, there's state-by-state detail on unemployment benefits for Massachusetts, California and New Jersey. If Sanofi offers you a package, our severance negotiation page has ideas for asking about its terms.

A sourced history of Sanofi layoffs

  • August 2026, Blueprint Medicines layoffs in Cambridge

    A Sanofi filing with Massachusetts listed 229 Blueprint Medicines workers to be cut between Oct. 9 and late June 2027, the Boston Globe reported, as Blueprint's buildings at 45 and 38 Sidney Street were closing, according to pharmaphorum's report.

  • April 2024, US vaccine sales restructuring

    Sanofi moved to cut positions in its U.S. vaccines commercial unit to streamline its sales structure, saying it was adapting to an evolving market, and said affected staff could apply for new positions, BioSpace reported, citing Endpoints News.

  • April 2024, Amunix divestiture and California site closing

    Sanofi said it would divest Amunix Pharmaceuticals, bought in December 2021, a move BioSpace said would eliminate 100 jobs at a San Francisco site from June 3, 2024. The closing notice to California is dated April 3, our WARN tracker shows.

  • April 2022, exit from Kadmon's New York site

    Sanofi decided to leave Kadmon's New York site in the third quarter of 2022, months after buying the company, and to lay off 25 people there, BioSpace reported. A spokesperson said they could apply for positions at Sanofi.

  • August 2021, Principia lab closing in California

    Sanofi moved to shut the labs of Principia, bought in 2020, under a California WARN notice effective October 8, BioSpace reported, days after a Principia drug failed a trial. That notice, for 38 jobs, is dated August 31 in our WARN tracker.

  • November 2018, Chattanooga consumer health jobs bound for New Jersey

    Sanofi said it was moving 160 Chattanooga consumer health jobs to New Jersey, the Times Free Press reported. Its December notice to Tennessee covered 180 jobs, 20 of them field representatives, according to WTVC.

  • February 2012, Genzyme research cuts in Massachusetts

    Sanofi said it had cut positions in Genzyme's research and development operations in Massachusetts to avoid redundancy between Sanofi and Genzyme staff, BioSpace reported.

  • October 2010, cut of 1,700 US pharmaceutical jobs announced

    Sanofi-Aventis said it was eliminating 1,700 U.S. pharmaceutical jobs, about 1,400 in sales and 300 in administration at its Bridgewater, N.J. headquarters, in a restructuring triggered by growing generic competition and other factors, the Associated Press reported.

What to do if you're laid off from Sanofi

Sanofi layoff and severance questions

What severance has Sanofi given laid-off employees?

In 2018 Sanofi said Chattanooga staff who couldn't find another Sanofi job or relocate would get packages of cash, continued health benefits and career transition services, the Times Free Press reported. The June 2025 Blueprint merger agreement had Sanofi match or better, for a year or a shorter employment period, the severance of each person Blueprint employed when the merger took effect, without giving employees third-party beneficiary rights. The Globe put the deal in July 2025, so that year ended before the filing's first layoff date, October 9, 2026.

Has Sanofi filed WARN notices for its layoffs?

Yes. Six filings from Sanofi and companies it owns, dated 2004 to 2026, are counted in our WARN tracker, two each from New Jersey and California and one each from Tennessee and Massachusetts. Blueprint Medicines' August 2026 notice is the only one from 2025 on.

Did Sanofi lay off Genzyme employees?

Yes. Genzyme's Massachusetts research staff lost positions in early 2012, when Sanofi said it was removing overlap with its own researchers, BioSpace reported. Massachusetts records in our WARN tracker begin in April 2021, so Genzyme notices from before then aren't in it.

Sources for this page